Evidence map›Paper›PMID 28573642›Full record

ArticleMedical oncology (Northwood, London, England)2017

Aberrant gene promoter methylation of E-cadherin, p16

Ati Burassakarn, Chamsai Pientong, Nuchsupha Sunthamala, Jureeporn Chuerduangphui, Patravoot Vatanasapt, Natcha Patarapadungkit, Bunkerd Kongyingyoes, Tipaya Ekalaksananan

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Analysis of DNA methylation of E-cadherin and p16Clinical and experimental dental research · 2021
    Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ati BurassakarnDepartment of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Chamsai PientongDepartment of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Nuchsupha SunthamalaDepartment of Microbiology, Faculty of Sciences, Mahasarakham University, Mahasarakham, Thailand.
Jureeporn ChuerduangphuiDepartment of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Patravoot VatanasaptDepartment of Otorhinolaryngology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Natcha PatarapadungkitDepartment of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Bunkerd KongyingyoesDepartment of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Tipaya EkalaksanananDepartment of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. tipeka@kku.ac.th.ORCID http://orcid.org/0000-0003-2406-2356
Khon Kaen University · THMahasarakham University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The etiology of oral carcinogenesis appears to be multifactorial. There is emerging evidence of the presence of Epstein-Barr virus (EBV) in epithelial oral squamous cell carcinoma (OSCC), but an association of EBV with oral carcinogenesis has not yet been established. Although epigenetic alterations, such as aberrant DNA methylation, are known to contribute to the pathogenesis of oral cancer, the relationship of such alterations with EBV infection is little known. This study aimed to investigate the association between EBV infection and promoter methylation patterns of tumor-associated genes in OSCC tissues. A total of 165 of formalin-fixed paraffin-embedded OSCC tissues were studied (68 of EBV positive and 97 of EBV negative). The promoter methylation patterns were investigated for four tumor-associated genes, E-cadherin, p16

Indexed as

AdultAgedAged, 80 and overAntigens, CDCadherinsCarcinoma, Squamous CellCyclin-Dependent Kinase Inhibitor p16DNA MethylationDNA Modification MethylasesDNA Repair EnzymesEpigenesis, GeneticEpstein-Barr Virus InfectionsFemaleHumansMaleMiddle AgedAntigens, CDCadherinsCDH1 protein, humanCyclin-Dependent Kinase Inhibitor p16DNA Modification MethylasesDNA Repair EnzymesMGMT protein, humanTumor Suppressor Protein p14ARFTumor Suppressor ProteinsEpigenetic changesEpstein–Barr virusOral squamous cell carcinomaPromoter methylation

Identifiers

PMID28573642
OpenAlexW2621075399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.